📰 Benevolent Platform News
Page 3 - Benevolent Platform News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Benevolent Platform. Real-time updates on events, politics, business and more.
May 17, 2022
Second novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's drug discovery platform and selected for AstraZeneca's drug development portfolioA total of three targets
April 25, 2022
/PRNewswire/ -- BenevolentAI (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company, announces that trading in its shares is...
April 21, 2022
BenevolentAI and Drugs for Neglected Disease initiative (DNDi) have commenced a joint AI research project to address dengue.
April 20, 2022
- The collaboration will use AI to identify potential biological targets and therapies that could be repurposed for dengue to prevent disease progression - Dengue is a climate-sensitive
January 13, 2022
/PRNewswire/ -- BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca,...
January 13, 2022
/PRNewswire/ -- BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca,...
January 13, 2022
LONDON, Jan. 13, 2022 /PRNewswire/ -- BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery ...
January 13, 2022
LONDON, Jan. 13, 2022 /PRNewswire/ -- BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery ...
January 13, 2022
Two novel targets identified through the existing collaboration have already been added to AstraZeneca's portfolio LONDON, Jan. 13, 2022 /PRNewswire/ -- BenevolentAI, a leading clinical-stage
January 13, 2022
The three-year expansion includes an upfront payment, research funding, development milestone payments and tiered royalties on future revenues